Philip Krause
Fortuna: 486 246 $ al 31/08/2026
Fortuna: 486 246 $ al 31/08/2026
Dr. Philip R.
Krause is on the Board of Directors at Mesoblast Ltd. Dr. Krause was previously employed as a Deputy Director by US Food & Drug Administration.
He received his undergraduate degree from the University of Illinois, a graduate degree from the University of Illinois, an MBA from Florida State University and a doctorate degree from Yale School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MESOBLAST LIMITED 0,02 % | 27/08/2026 | 287.500 ( 0,02 % ) | 486 246 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MESOBLAST LIMITED | Director/Miembro de la Junta | 24/03/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.